CJ Bioscience, Inc. (KOSDAQ:311690)
8,590.00
-260.00 (-2.94%)
At close: Feb 13, 2026
-13.93% (1Y)
| Market Cap | 112.23B -10.4% |
| Revenue (ttm) | 3.38B -14.9% |
| Net Income | -28.31B |
| EPS | -2,313.72 |
| Shares Out | 13.07M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 24,979 |
| Average Volume | 33,662 |
| Open | 8,900.00 |
| Previous Close | 8,850.00 |
| Day's Range | 8,570.00 - 8,900.00 |
| 52-Week Range | 8,000.00 - 12,930.00 |
| Beta | 0.48 |
| RSI | 46.82 |
| Earnings Date | Mar 19, 2026 |